Survival With Patients Treated With Salivary Gland Cancer

Completed

• Conditions: Salivary Gland Neoplasms; Salivary Gland Cancer
• Interventions: Procedure: Surgical intervention with or without postoperative adjuvant therapy

• Registration Number: NCT05390294
• Lead Sponsor: Clinical Center of Vojvodina

Brief Summary

Salivary gland malignancies is very heterogenous group of tumors regarding tumor histology and localization. The aim of this study is to assess main clinical and pathological parameters related to patients survival

Detailed Description

The retrospective study enrolled medical charts of the patients treated due to salivaly gland cancers in the Clinic for maxillofacial surgery at Clinical center of Vojvodina in the period of 1. January 1996. to 31. December 2021. Patients demographics, type of the tumor, localization, TNM status and patohystological parameters were evaluated for patients survival and disease free periods

Study Timeline

• Study Start: 2022-01-01
• Primary Completion: 2022-03-30
• Study Completion: 2022-04-30
• Status Verified: 2022-05
• Study First Submitted: 2022-05-18
• Study First Submitted QC: 2022-05-22
• Last Update Submitted: 2022-05-22
• Study First Posted: 2022-05-25
• Last Update Posted: 2022-05-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

Patients with salivary gland malignancies treted in the Clinic for maxillofacial surgery

Exclusion Criteria

Incomplete medical data Patients with metastatic tumord of salivary gland Patients with recurrent malignancies of salivary glands sent from other clinics

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Patients free of the disease	Surgical intervention with or without postoperative adjuvant therapy	Patients treated due to SGC without local recurrence or metastases
Patients with the disease	Surgical intervention with or without postoperative adjuvant therapy	Patient with relapse of SGC, metastases or died due to SGC

Primary Outcome Measures

Name	Time	Method
Patients survival	Through study completion, an average of 1 year	Survival of patients treated due to SGC during observation period of minimum 2 years

Trial Locations

Locations (1)

Clinic for maxillofacial surgery Clinical center of Vojvodina; 🇷🇸 Novi Sad, Serbia